Home > Drug Search >
  • company_query: Advenchen Laboratories
  •   > 
Drug Filter
Category:
chemistry (18) biology (7)
Status:
Approved (1) Withdrawn (1) NDA Filing (1) Phase Ⅲ (6) Phase Ⅱ (7) Phase Ⅰ (8) IND Filing (1)
Clinical Stage:
Pending (2) Active (18) Discontinued (3)
Bio-Type:
Gene therapy (1) Vaccine (6)
Indication:
Advanced renal cell carcinoma (RCC) (1) Angina pectoris (1) Breast cancer (1) Chronic lymphocytic leukemia (CLL) (1) Chronic obstructive pulmonary disease (COPD) (1) Colorectal neoplasms (1) Crohn's disease (1) Duchenne muscular dystrophy (DMD) (1) Gastric cancer (1) Hepatocellular carcinoma (HCC) (1) HIV infection (1) Hypertension (1) Medullary thyroid cancer (MTC) (1) Melanoma (1) Metastatic breast cancer (1) Metastatic colorectal cancer (CRC) (1) Multiple myeloma (MM) (1) Multiple sclerosis (MS) (1) Non small cell lung cancer (NSCLC) (4) Osteoarthritis (OA) (1) Ovarian cancer (1) Pancreatic cancer (1) Prostate cancer (2) Rheumatoid arthritis (RA) (1) Dermal scarring (1) Small cell lung cancer (SCLC) (1) Soft tissue sarcoma (1) Solid tumours (2) Rotavirus infection (1) Metabolic disorders (1) Type 2 diabetes (2) Ulcerative colitis (1) Leg ulcer (1) Colorectal cancer (2) Bacteraemia (1) Colon cancer (1) Diabetic foot ulcers (1) Homozygous familial hypercholesterolemia (1) Hyperphosphatemia (1) Autoimmune diseases (1) Sporadic inclusion body myositis (sIBM) (1) Plaque psoriasis (1) Advanced gastric adenocarcinoma (1) Liver cancer (2) Human papillomavirus infections (HPV) (1)
Others:
Sort: Aprv. Year Alphabetical Prev Next
First Prev 1 2 Next Last GO
Recently Viewed Drugs:
Insert title here
Feed-Back To Top
ICP Permit 14047345| Beijing PSB Hai Dian Record 11010802017043 |(京)-经营性-2015-0023(互联网药品信息服务资格证书)
Insert title here
Feed-Back To Top